Rezolute, Inc. (RZLT)
2.39
+0.04
(+1.70%)
USD |
NASDAQ |
Jan 08, 16:00
2.35
-0.04
(-1.67%)
After-Hours: 19:51
Rezolute Research and Development Expense (Annual): 61.53M for June 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.74B |
| Geron Corp. | 103.74M |
| XOMA Royalty Corp. | 2.875M |
| CorMedix, Inc. | 3.942M |
| Sarepta Therapeutics, Inc. | 778.47M |